• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 6th March 2017

New Member of the EuroQol Group: OHE’s Dr Yan Feng

OHE’s Yan Feng becomes a member of the EuroQol Research Foundation. Dr Yan Feng, Senior Economist at OHE, has been awarded membership of the EuroQol Research Foundation, the not-for profit research organisation which developed the EQ-5D, a widely used measure of…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Yan-Feng-V1

OHE’s Yan Feng becomes a member of the EuroQol Research Foundation.

Dr Yan Feng, Senior Economist at OHE, has been awarded membership of the EuroQol Research Foundation, the not-for profit research organisation which developed the EQ-5D, a widely used measure of self-reported health.

Dr Feng has been involved in statistical and econometric analysis of EQ-5D data since 2011, working closely with OHE’s Professor Nancy Devlin, Mike Herdman, Koonal Shah and OHE Senior Fellow Professor David Parkin. She has made important contributions to OHE’s research on health outcomes, including both methodological and applied EQ-5D research.

Dr Feng is currently principal investigator on a number of projects including:

  1. Revisiting the Measurement and Valuation of Health (MVH) study: new methods for modelling UK valuations for the EQ-5D-3L, in collaboration with Professor Ben van Hout (University of Sheffield) and Professor Nancy Devlin;
  2. Understanding the relationship between clinical quality of primary care and patient self-reported health on the EQ-5D in England, in collaboration with Professor Hugh Gravelle (University of York) and Professor Nancy Devlin;
  3. Exploring the inconsistent ordering of the EQ-5D-5L value set, in collaboration with Professor Gordon G Liu (Peking University) and Professor Nancy Devlin.

She is also contributing econometric expertise to a wide range of projects, including ‘Anchoring discrete choice experiment values at 0 for the EQ-5D-Y’; ‘Developing an EQ-5D-5L value set for Australia using the EQ-VT protocol’; and ‘New methods for analysing the distribution of EQ-5D observations’. Yan is also leading the work to model an EQ-5D-5L value set for the UK, building on the value set for England (currently under review with a peer review journal).

Professor Nancy Devlin comments, “We are delighted that Yan has been offered membership of the EuroQol Group. This is a well-deserved recognition of the excellent work she has been undertaking on econometric analysis of EQ-5D data over a number of years, and the substantial ongoing programme of work Yan has planned in this area”. 

Yan’s recent publications relating to the EQ-5D include the following:

  • Parkin, D., Devlin, N., Feng, Y., 2016. What determines the shape of an EQ-5D index distribution? (Open access article). Medical Decision Making, 36, pp.941. 
  • Feng, Y., Herdman, M., van Nooten, F., Cleeland, C., Parkin, D., Ikeda, S., Igarashi, A., and Devlin, N. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D (under revision with journal).
  • Cole, A., Shah, K., Mulhern, B., Feng, Y., Devlin, N., 2016. Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment (under revision with journal).
  • Feng, Y, Hole, A., Karimi, M., Tsuchiya, A. and van Hout, B., 2016 (these authors are ordered alphabetically).  An exploration of the non-iterative time trade off. Presented at the EuroQol Research Foundation’s 33rd plenary meeting in September 2016.
  • Feng, Y., Devlin, N., Bateman, A., Zamora, B., Parkin, D., 2016. The distribution of the EQ-5D-5L Index in patient populations. OHE Research Paper. London: Office of Health Economics. 
  • Feng, Y., Devlin, N., Liu, G., 2016. Exploring the inconsistent ordering of the EQ-5D-5L value set. Presented at the UK Health Economist Study Group meeting in June 2016.
  • Zamora, B., Parkin, D., Feng, Y., Bateman, A., Herdman, M., Devlin, N., 2017. New methods for analysing the distribution of EQ-5D observations. Presented at the UK Health Economists Study Group meeting in January 2017.
  • Feng, Y., Devlin, N., Herdman, M., 2015. Assessing the health of the general population in England: how do the EQ-5D 3L and 5L versions compare? Health and Quality of life Outcomes, 13, pp.171.
  • Feng, Y., Parkin, D., Devlin, N., 2014. Assessing the performance of the EQ-VAS in the NHS PROMS programme. Quality of Life Research, 23(3), pp.977. 
  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes

Related News

NGS report_AdobeStock_406823942_landscape
  • News
  • July 2023

NGS testing for lung cancer across Europe still limited, despite clear case for adoption

Read more
IRA-course-graphic-for-website-news-FINAL-1
  • News
  • May 2023

New free educational program launched – Explaining the U.S. Inflation Reduction Act

Read more
Group 11119
  • News
  • February 2023

Applications open for MSc Fellowship Programme 2023

Read more
Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!